Occam Recruits CBO for Parisian Generative AI Drug Discovery Platform Company, Iktos
In January 2024, Occam recruited Avirup Bose, Ph.D., as Chief Business Officer of Iktos, a Paris-based biotech leveraging Artificial Intelligence for new drug design and an M Ventures investment.
Avirup previously served as VP of Business Development at Chinook Therapeutics (NASDAQ: KDNY), where he was instrumental in engineering many important strategic collaboration agreements. Chinook was acquired by Novartis in 2023. Prior to Chinook, Bose spent 17 years at Novartis, where he held positions of increasing responsibility in research, portfolio management, licensing, and business development.
Occam is a globally recognized leader in recruiting AI innovators for the life sciences. Check out Occam President John Holdonak's recent blog on the AI-ML Revolution in Drug R&D.
Occam Global is an executive recruiting and leadership advisory firm with specialties across technological fields including Biotech, TechBio, AI-ML, Cell/Gene Therapy, Diagnostics/Genomics, Medical Devices, Research Tools, Digital Health, Alternative Energy, AgTech, EdTech, Robotics as well as adjacencies within Venture Capital and Private Equity. Occam helps build leadership teams that meet the demands of the rapidly developing, competitive, and challenging industries it serves. Occam Global recruits leading C-Suite executives and board members for the most exciting and innovative clients across the world with a specific focus on the UK, Continental Europe, the US, and Asia.